Financials
- Market Capitalization 154.72 M
- Employee 70
- Founded 2016
- CEO N/A
- Website www.tenayatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00FPMK2S3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3725 | LENZ LENZ Therapeutics, Inc. - Common Stock | 5.11 USD | +6.24% | +9.89% | -10.19% | -84.28% | 160.56 M USD | ||
| 3735 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | +3.23% | -37.25% | +55.15% | 155.81 M USD | ||
| 3744 | NRXP NRX Pharmaceuticals, Inc. - Common Stock | 3.55 USD | -1.93% | -0.28% | +16.01% | +99.44% | 153.70 M USD | ||
| 3748 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -1.72% | -8.06% | -36.67% | -40.00% | 151.90 M USD |
Frequently asked questions about Tenaya Therapeutics, Inc. Common Stock
What is the Tenaya Therapeutics, Inc. Common Stock stock price today?
The current price of Tenaya Therapeutics, Inc. Common Stock (TNYA) is 0.69. Over the past 24 hours, the stock has changed by -1.43%. Follow the TNYA chart for real-time price dynamics.
What is the stock ticker of Tenaya Therapeutics, Inc. Common Stock?
Tenaya Therapeutics, Inc. Common Stock trades under the ticker TNYA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Tenaya Therapeutics, Inc. Common Stock stock going up?
TNYA has changed by -1.43% over the last week, -5.48% over the last month, and -38.39% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Tenaya Therapeutics, Inc. Common Stock?
Tenaya Therapeutics, Inc. Common Stock currently has a market capitalization of 154.72 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Tenaya Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Tenaya Therapeutics, Inc. Common Stock reported earnings of -0.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Tenaya Therapeutics, Inc. Common Stock revenue for the last quarter?
Tenaya Therapeutics, Inc. Common Stock reported quarterly revenue of 1.11 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Tenaya Therapeutics, Inc. Common Stock net income for the last quarter?
Tenaya Therapeutics, Inc. Common Stock reported net income of -43.39 M for the last quarter. The previous quarter showed -19.27 M, which means net income changed by -125.16%.
How many employees does Tenaya Therapeutics, Inc. Common Stock have?
As of the latest available data, Tenaya Therapeutics, Inc. Common Stock has 70 employees. Workforce size can provide additional context about the company's scale and operations.
What is Tenaya Therapeutics, Inc. Common Stock EBITDA?
Tenaya Therapeutics, Inc. Common Stock EBITDA is -42.39 M, and its EBITDA margin is -3 818.92%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Tenaya Therapeutics, Inc. Common Stock stock?
You can buy Tenaya Therapeutics, Inc. Common Stock (TNYA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Tenaya Therapeutics, Inc. Common Stock stock?
Investing in Tenaya Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TNYA chart and related analysis on metatrader.com as part of your research.